Vibrio cholerae O1 variant with reduced susceptibility to ciprofloxacin, Western Africa - PubMed (original) (raw)

Vibrio cholerae O1 variant with reduced susceptibility to ciprofloxacin, Western Africa

Marie Laure Quilici et al. Emerg Infect Dis. 2010 Nov.

No abstract available

PubMed Disclaimer

Similar articles

• Haitian variant ctxB producing Vibrio cholerae O1 with reduced susceptibility to ciprofloxacin is persistent in Yavatmal, Maharashtra, India, after causing a cholera outbreak.
  Kumar P, Mishra DK, Deshmukh DG, Jain M, Zade AM, Ingole KV, Yadava PK. Kumar P, et al. Clin Microbiol Infect. 2014 May;20(5):O292-3. doi: 10.1111/1469-0691.12393. Epub 2013 Nov 4. Clin Microbiol Infect. 2014. PMID: 24102849
• Vibrio cholerae O1 with ctxB7 variant genotype acquired qnrVC mediated ciprofloxacin resistance in Yavatmal, India.
  Kumar P, Yadav P, Deshmukh DG, Bulle PA, Singh D, Singh N, Sharma KK, Jain M, Ingole KV, Goel AK, Yadava PK. Kumar P, et al. Clin Microbiol Infect. 2017 Dec;23(12):1005-1006. doi: 10.1016/j.cmi.2017.06.019. Epub 2017 Jun 23. Clin Microbiol Infect. 2017. PMID: 28648857 No abstract available.
• Unique Clones of Vibrio cholerae O1 El Tor with Haitian Type ctxB Allele Implicated in the Recent Cholera Epidemics from Nigeria, Africa.
  Adewale AK, Pazhani GP, Abiodun IB, Afolabi O, Kolawole OD, Mukhopadhyay AK, Ramamurthy T. Adewale AK, et al. PLoS One. 2016 Aug 1;11(8):e0159794. doi: 10.1371/journal.pone.0159794. eCollection 2016. PLoS One. 2016. PMID: 27479360 Free PMC article.
• [Vibrio cholerae serogroups O1 and O139: susceptibility to antibiotics during 7th cholera pandemic].
  Andrusenko IT, Lomov IuM, Moskvitina EA, Podosinnikova LS, Ivanova SM. Andrusenko IT, et al. Zh Mikrobiol Epidemiol Immunobiol. 2008 May-Jun;(3):107-14. Zh Mikrobiol Epidemiol Immunobiol. 2008. PMID: 18595476 Review. Russian.
• Whole-genome sequence comparisons reveal the evolution of Vibrio cholerae O1.
  Kim EJ, Lee CH, Nair GB, Kim DW. Kim EJ, et al. Trends Microbiol. 2015 Aug;23(8):479-89. doi: 10.1016/j.tim.2015.03.010. Epub 2015 Apr 24. Trends Microbiol. 2015. PMID: 25913612 Review.

Cited by

• Complete genome sequence of the pandrug-resistant Vibrio cholerae strain KBR06 isolated from a cholera patient in Bangladesh.
  Kabir MM, Imam MR, Farzana Z, Hossain CF. Kabir MM, et al. Microbiol Resour Announc. 2023 Dec 14;12(12):e0057723. doi: 10.1128/MRA.00577-23. Epub 2023 Nov 15. Microbiol Resour Announc. 2023. PMID: 37966233 Free PMC article.
• Diarrhea-Causing Bacteria and Their Antibiotic Resistance Patterns Among Diarrhea Patients From Ghana.
  Afum T, Asandem DA, Asare P, Asante-Poku A, Mensah GI, Musah AB, Opare D, Taniguchi K, Guinko NM, Aphour T, Arhin D, Ishikawa K, Matano T, Mizutani T, Asiedu-Bekoe F, Kiyono H, Anang AK, Koram KA, Yeboah-Manu D. Afum T, et al. Front Microbiol. 2022 May 19;13:894319. doi: 10.3389/fmicb.2022.894319. eCollection 2022. Front Microbiol. 2022. PMID: 35663873 Free PMC article.
• Investigating the virulence genes and antibiotic susceptibility patterns of Vibrio cholerae O1 in environmental and clinical isolates in Accra, Ghana.
  Abana D, Gyamfi E, Dogbe M, Opoku G, Opare D, Boateng G, Mosi L. Abana D, et al. BMC Infect Dis. 2019 Jan 21;19(1):76. doi: 10.1186/s12879-019-3714-z. BMC Infect Dis. 2019. PMID: 30665342 Free PMC article.
• Antimicrobial resistance of Vibrio cholerae from sub-Saharan Africa: A systematic review.
  Mohammed Y, Aboderin AO, Okeke IN, Olayinka AT. Mohammed Y, et al. Afr J Lab Med. 2018 Dec 6;7(2):778. doi: 10.4102/ajlm.v7i2.778. eCollection 2018. Afr J Lab Med. 2018. PMID: 30643734 Free PMC article. Review.
• Accessory Toxins of Vibrio Pathogens and Their Role in Epithelial Disruption During Infection.
  Pérez-Reytor D, Jaña V, Pavez L, Navarrete P, García K. Pérez-Reytor D, et al. Front Microbiol. 2018 Sep 20;9:2248. doi: 10.3389/fmicb.2018.02248. eCollection 2018. Front Microbiol. 2018. PMID: 30294318 Free PMC article. Review.

References

1. 1. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing; 18th informational supplement. CLSI document M100–S18. Wayne (PA): The Institute; 2008.
2. 1. Baranwal S, Dey K, Ramamurthy T, Nair GB, Kundu M. Role of active efflux in association with target gene mutations in fluoroquinolone resistance in clinical isolates of Vibrio cholerae. Antimicrob Agents Chemother. 2002;46:2676–8. 10.1128/AAC.46.8.2676-2678.2002 - DOI - PMC - PubMed
3. 1. Goel AK, Jiang SC. Genetic determinants of virulence, antibiogram and altered biotype among the Vibrio cholerae O1 isolates from different cholera outbreaks in India. Infect Genet Evol. 2010;10:815–9. 10.1016/j.meegid.2009.06.022 - DOI - PubMed
4. 1. Ansaruzzaman M, Bhuiyan NA, Nair GB, Sack DA, Lucas M, Deen JL, et al. Cholera in Mozambique, variant of Vibrio cholerae. Emerg Infect Dis. 2004;10:2057–9. - PMC - PubMed
5. 1. Safa A, Sultana J, Cam PD, Mwansa JC, Kong RY. Vibrio cholerae O1 hybrid El Tor strains, Asia and Africa. Emerg Infect Dis. 2008;14:987–8. 10.3201/eid1406.080129 - DOI - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • PubMed Central

• Medical

  • MedlinePlus Health Information